Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Teva to expand in Spain with Bentley buy
Teva Pharmaceutical is on an expansion quest. Today it's agreed to buy Bentley Pharmaceuticals, which is heavily entrenched in Spain and sells generics in other E.U. countries. The company will dovetail nicely with Teva Spain and serve as a platform for growth there, its president and CEO said. The $360 million cash deal is subject to Bentley's previously planned spin-off of its drug-delivery business to its shareholders. Regulators also will have to clear the deal.
The buyout announcement comes just two weeks after Teva announced it would spend $100 million build a new plant in the Czech Republic and create 400 new jobs there.
- here's the release
- read the MarketWatch news
Related Articles:
Teva Pharmaceutical--Best Pharma Stocks of 2007. Report
Bentley Pharmaceutical--Best Pharma Stocks of 2007. Report
Teva plans aggressive move into biogenerics. Report
Analysts get bullish on generics makers. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
